• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,237.99 -160.73
( -0.21%)
Global Indices
Nasdaq
49,543.85 -540.61
(-1.08%)
Dow Jones
7,428.26 -93.98
(-1.25%)
Hang Seng
61,141.50 -1,512.55
(-2.41%)
Nikkei 225
10,172.40 -200.53
(-1.93%)
Forex
USD-INR
95.71 0.07
(0.07%)
EUR-INR
111.93 -0.13
(-0.12%)
GBP-INR
129.01 -0.31
(-0.24%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
103.35
451074.97
EPS(TTM)
Face Value()
Div & Yield %
18.19
1
0.85
 

PDS consolidated net profit rises 21.71% in the March 2026 quarter
May 16,2026
Net profit of PDS rose 21.71% to Rs 49.05 crore in the quarter ended March 2026 as against Rs 40.30 crore during the previous quarter ended March 2025. Sales declined 0.19% to Rs 3519.03 crore in the quarter ended March 2026 as against Rs 3525.77 crore during the previous quarter ended March 2025.

For the full year,net profit declined 28.81% to Rs 111.69 crore in the year ended March 2026 as against Rs 156.89 crore during the previous year ended March 2025. Sales rose 4.23% to Rs 13110.08 crore in the year ended March 2026 as against Rs 12577.99 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3519.033525.77 0 13110.0812577.99 4
OPM %3.423.95 -2.923.63 -
PBDT114.58119.62 -4 336.35379.23 -11
PBT78.3184.10 -7 205.45268.49 -23
NP49.0540.30 22 111.69156.89 -29